FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

 OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                       
1. Name and Address of Reporting Person * Slack David W. 2. Date of Event Requiring Statement (MM/DD/YYYY)
9/15/2022 

 3. Issuer Name and Ticker or Trading Symbol LISATA THERAPEUTICS, INC. [LSTA]
(Last)        (First)        (Middle)
110 ALLEN ROAD, 2ND FLOOR		 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
President & CBO /
(Street)
BASKING RIDGE, NJ 07920      
(City)              (State)              (Zip)
 5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)  3/31/2021 (1) 12/3/2029  Common Stock  10676.0  $4.22  D   
Stock Option (Right to Buy)  12/29/2021 (2) 12/29/2030  Common Stock  244213.0  $3.6  D   

Explanation of Responses:
(1)  Twenty-five percent (25%) of the shares issuable upon exercise of the options (the "Option Shares") shall vest on the last day of each three-month period following December 3, 2019 (the "Grant Date"), such that all of the Option Shares shall be vested on the one-year anniversary of the Grant Date.
(2)  Twenty-five percent (25%) of the Option Shares will be vested and exercisable upon the one (1) year anniversary of December 29, 2020 (the "Grant Date"); and the remaining Option Shares will vest and become exercisable in a series of thirty-six (36) successive equal monthly installments, rounded downward to the nearest whole share, measured from the first (1st) anniversary of the Grant Date, such that 100% of the Option Shares will be vested and exercisable upon the fourth (4th) anniversary of the Grant Date.

Remarks:
Exhibit List: Exhibit 24, Power of Attorney

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Slack David W.
110 ALLEN ROAD
2ND FLOOR
BASKING RIDGE, NJ 07920		 X
President & CBO

Signatures
James Nisco, Attorney-in-fact for David Slack 9/16/2022
**Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Lisata Therapeutics (NASDAQ:LSTA)
Historical Stock Chart
From Dec 2022 to Jan 2023 Click Here for more Lisata Therapeutics Charts.
Lisata Therapeutics (NASDAQ:LSTA)
Historical Stock Chart
From Jan 2022 to Jan 2023 Click Here for more Lisata Therapeutics Charts.